Pfützner Andreas, Pfützner Anke, Hanna Mina, Demircik Filiz, Sachsenheimer Daniela, Wittig Tobias, de Faire Johan
Pfützner Science & Health Institute, Mainz, Germany.
Institute for Internal Medicine and Laboratory Medicine, University for Digital Technology in Medicine and Dentistry, Wiltz, Luxembourg.
Nutr Metab Insights. 2023 Jan 15;16:11786388221141174. doi: 10.1177/11786388221141174. eCollection 2023.
We conducted a prospective placebo-controlled double-blind randomized Study to assess the impact of a single dose of a nutritional Supplement (AB001) on alcohol absorption in healthy subjects. Other objectives were the impact on breath alcohol content, cognitive function 1 hour after alcohol uptake and tolerability.
A total of 24 healthy volunteers were enrolled into the study (12 male, 12 female, age: 28.3 ± 10.8 years, BMI: 23.5 ± 5.7 kg/m²). On the experimental day, they ingested a light breakfast together with a single dose (2 capsules) of AB001 (or placebo) and drank 2 moderate glasses of spirit (a total of 0.6 g/kg body weight). Breath alcohol tests and blood draws for determination of blood alcohol levels were performed for up to 6 hours. After crossover, the experiment was repeated in the following week. Areas under the curves were calculated to determine alcohol absorption rates.
There was a significant reduction of blood alcohol by 10.1% ( < .001) with AB001, when compared to placebo. There was a less pronounced but also significant reduction of alcohol in the breath test by 7.2% ( < .05). No difference in the cognitive function test between AB001 and placebo could be observed 60 minutes after alcohol ingestion (22.6 ± 8.0 seconds vs 23.0 ± 11.2 seconds, n.s.). The supplement uptake was well tolerated and there were no adverse events related to the study intervention.
Uptake of a single dose of AB001 shortly before drinking alcohol significantly reduced plasma alcohol and breath alcohol concentrations, but the effect was less pronounced compared to chronic uptake as shown previously.
我们进行了一项前瞻性安慰剂对照双盲随机研究,以评估单剂量营养补充剂(AB001)对健康受试者酒精吸收的影响。其他目标包括对呼气酒精含量、饮酒后1小时认知功能的影响以及耐受性。
共有24名健康志愿者参与该研究(12名男性,12名女性,年龄:28.3±10.8岁,体重指数:23.5±5.7kg/m²)。在实验当天,他们一起食用了一份清淡早餐以及单剂量(2粒胶囊)的AB001(或安慰剂),并饮用了2中杯烈酒(总计0.6g/kg体重)。进行呼气酒精测试和采血以测定血酒精水平,持续长达6小时。交叉后,在接下来的一周重复该实验。计算曲线下面积以确定酒精吸收率。
与安慰剂相比,AB001使血酒精显著降低了10.1%(P<0.001)。呼气测试中的酒精降低程度虽不那么明显,但也显著降低了7.2%(P<0.05)。饮酒后60分钟,AB001与安慰剂在认知功能测试中未观察到差异(22.6±8.0秒对23.0±11.2秒,无显著性差异)。补充剂的摄入耐受性良好,且没有与研究干预相关的不良事件。
饮酒前不久摄入单剂量AB001可显著降低血浆酒精和呼气酒精浓度,但与之前所示的长期摄入相比,效果不那么明显。